Else Nutrition Holdings Inc suffered a significant drop in stock price, losing over 11% in just one trading day.
In the latest trading session, Else Nutrition Holdings Inc (BABY.TO) closed down 11.11% at CA$0.02. This decline raises concerns about the company's financial health and future prospects, especially given recent operational challenges and market conditions.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Else Nutrition Holdings Inc
BABY.TO
BABY.TO
Else Nutrition Holdings Inc
WealthAwesomeMarket cap
$1.15M
52W high
$0.25
52W low
$0.01
1W change
+0.00%
Beta
0.97
Analyst Price Targets
Based on analyst covering BABY
Wall Street analysts forecast BABY stock price to rise 24900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.00
+24900.0% Upside
Current Price
C$0.02
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BABY's historical volatility
30-Day Vol
183.7%
Annualized
90-Day Vol
178.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 โ C$0.04 |
| 60 trading days | C$0.02 | C$0.01 โ C$0.04 |
| 90 trading days | C$0.02 | C$0.01 โ C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep a close eye on Else Nutrition's financial performance and market strategies, particularly after its recent revenue decline, as the company works towards profitability.
11.11% Decline in Stock Price
Else Nutrition's stock fell to CA$0.02, reflecting investor worries about its financial performance and market viability.
Bull case
Despite the recent drop, Else Nutrition has made progress in cutting operating expenses and achieving a gross profit in Q3 2025. If managed well, these improvements could indicate a potential turnaround for the company.
Bear case
The significant revenue decline from CA$8.0 million in 2024 to CA$6.0 million in 2025 raises doubts about the company's growth trajectory and its ability to sustain operations.
Recent Financial Performance
Else Nutrition reported a revenue decrease to CA$6.0 million for fiscal year 2025, down from CA$8.0 million in 2024. While operating expenses were significantly reduced, the overall financial outlook remains concerning, especially given the company's negative profit margin.
Market Reaction
The 11.11% drop in Else Nutrition's stock price reflects investor skepticism about the company's ability to recover from its recent financial setbacks. With a market cap of CA$1.29 million, the stock's volatility raises questions about its long-term viability in the competitive nutrition market.
Future Outlook
While Else Nutrition aims to expand into the adult nutrition market and has shown operational improvements, the recent financial results may shake investor confidence. Stakeholders will need to watch for further developments, particularly regarding the company's plans for growth and profitability.
Advertisement
